Chronic Lower Back Pain Treatment Market Size, Share And Global Trend By Treatment Type (Analgesic Medications, Nonsteroidal Anti-Inflammatory Drugs, Anticonvulsants, Antidepressants, Others), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Others), And Geography Forecast Till 2022-2029

Chronic lower back pain is one of the prominent health condition witnessed by an estimated 80.0% of the population, at some point of their life, across the globe, also, chronic lower back pain is primarily responsible for the occurrence of global mobility disability. According to data published by National Statistics in 2018, an estimated one-third of the U.K. population suffers from lower back pain. Certain factors such as sprains and strains, intervertebral disc degeneration, herniated or ruptured discs, radiculopathy, and skeletal irregularities are responsible to cause chronic lower back pain. Moreover, certain risk factors such as sedentary lifestyle, pregnancy, obesity, aging, occupational injuries, and mental disturbances may lead to the occurrence of chronic lower back pain. In order to diagnose the chronic lower back pain, MRI scan, X-Ray, CT scan, and blood scans are widely prescribed by physicians across the globe.

Exponentially increasing prevalence of chronic lower back pain is projected to boost the growth of the global chronic lower back pain treatment market. Moreover, introducing new applications on the digital platform are expected to spread awareness about the chronic lower back pain which may propel the growth of the global chronic lower back pain treatment market during the forecast period.

To gain extensive insights into the market, Request for Customization

Certain factors such as lack of awareness amongst people regarding the severity of chronic lower back pain and reluctance of the population to diagnose and treat the chronic condition are expected to restrain the growth of the chronic lower back pain treatment market by 2026.

Key Players Covered

Some of the key players operating in the global chronic lower back pain treatment market are Medtronic, KARL STORZ SE & Co. KG, B. Braun Melsungen AG, Stryker, Zimmer Biomet, and others.

SEGMENTATION

Among the segmentation, surgery in the treatment type segment is expected to hold a significant share in the global chronic lower back pain treatment market owing to higher adoption of surgical procedures with the aim to treat the chronic condition.

Key Insights

• Prevalence of chronic lower back pain for key countries
• New product and therapy introduction for treatment of chronic lower back pain
• Technological advancements in the global chronic lower back pain market
• Key mergers and acquisitions

Regional Analysis

North America is projected to dominate the global chronic lower back pain treatment market owing to awareness amongst people regarding chronic lower back pain, increasing the prevalence of the chronic lower back pain, higher per capita healthcare expenditure and rising emphasis on prevention of chronic lower back pain. Asia Pacific is expected to register comparatively higher CAGR owing to the increasing prevalence of the chronic condition, developing healthcare infrastructure and increasing patient pool.

Key Industry Developments

• In May 2019, the association of Kaia Health, pain management specialists and physicians developed and launched an artificial intelligence based low back pain management app, Kaia app, with aim to educate and spread awareness about prevention of chronic lower back pain amongst the population.
• In January 2017, Teladoc Health launched its new program, Teladoc Back Care, with aim to spread awareness about the treatment for the chronic lower back pain.
• In November 2018, Rockefeller Neuroscience Institute at West Virginia University initiated a clinical trial to validate the efficacy and safety of non-opioid micropellet implant in the treatment of chronic back pain.